CLASS | DRUG/TOX | LP7790-1 |
COMPONENT | Pyrazinamide | LP15007-5 |
PROPERTY | MCnc | LP6827-2 |
TIME_ASPCT | Pt | LP6960-1 |
SYSTEM | Ser/Plas | LP7576-4 |
SCALE_TYP | Qn | LP7753-9 |
parent | Pyrazinamide | Serum or Plasma | Drug toxicology | LP389128-2 |
CLASSTYPE | Laboratory class | |
ORDER_OBS | Both | |
EXAMPLE_UNITS | ug/mL | |
EXAMPLE_UCUM_UNITS | ug/mL | |
UNITSREQUIRED | Y |
LONG_COMMON_NAME | en-US | Pyrazinamide [Mass/volume] in Serum or Plasma |
LONG_COMMON_NAME | en-US | Pyrazinamide [Mass/volume] in Serum or Plasma |
SHORTNAME | en-US | PZA SerPl-mCnc |
ConsumerName | en-US | Pyrazinamide, Blood |
SHORTNAME | es-AR | pirazinamida:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo: |
SHORTNAME | pt-BR | PZA SerPl-mCnc |
LONG_COMMON_NAME | de-DE | Pyrazinamid [Masse/Volumen] in Serum oder Plasma |
LONG_COMMON_NAME | fr-FR | Pyrazinamide [Masse/Volume] Sérum/Plasma ; Numérique |
LONG_COMMON_NAME | nl-NL | Pyrazinamide [massa/volume] in serum of plasma |
LONG_COMMON_NAME | es-MX | Pirazinamida: Suero o Plasma : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.77